Blinatumomab

(Synonyms: bscCD19xCD3; AMG-103; MEDI-538; MT-103; BLINCYTO)
3 Cited Publications
Avis client

Based on 3 publication(s) in Google Scholar

Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 97.33%
  • CAS No.: 853426-35-4
  • Masse moléculaire:54.09 kDa
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
Customer Validation & Images
Others
  • Others
100 mg

Obtenir un devis En stock

Please select quantity
Amount: USD 0.00